Achieve Life Sciences (ACHV) Capital Expenditures (2010 - 2023)
Achieve Life Sciences (ACHV) posted Capital Expenditures of $6000.0 for Q4 2023, up 100.0% on a QoQ basis from $3000.0 in Q3 2020.
Achieve Life Sciences (ACHV) Capital Expenditures (2010 - 2023) Analysis & Trends
Achieve Life Sciences' Capital Expenditures history runs 12 years deep, the most recent figure standing at $6000.0 for Q4 2023.
- Quarterly Capital Expenditures changed N/A year-over-year to $6000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $21000.0 (changed N/A YoY) and the FY2025 annual result came in at $3000.0, changed N/A from the prior year.
- Capital Expenditures was $6000.0 for Q4 2023 at Achieve Life Sciences, up from $3000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $54000.0 in Q1 2019 and bottomed at -$2000.0 in Q2 2019.
- A 3-year average of $10857.1 and a median of $3000.0 in 2020 frame the typical range for Capital Expenditures.
- Peak annual rise in Capital Expenditures reached 700.0% in 2020, while the deepest fall reached 96.3% in 2020.
- Achieve Life Sciences' Capital Expenditures stood at $1000.0 in 2019, then jumped by 200.0% to $3000.0 in 2020, then jumped by 100.0% to $6000.0 in 2023.
- Business Quant data shows ACHV's Capital Expenditures at $6000.0 in Q4 2023, $3000.0 in Q3 2020, and $12000.0 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Achieve Life Sciences | 2.54 Mn | 2.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 6,000.00 |
| Dec 31, 2023 | 6,000.00 |
| Sep 30, 2020 | 3,000.00 |
| Sep 30, 2020 | 3,000.00 |
| Jun 30, 2020 | 12,000.00 |
| Jun 30, 2020 | 12,000.00 |
| Mar 31, 2020 | 2,000.00 |
| Mar 31, 2020 | 2,000.00 |
| Dec 31, 2019 | 1,000.00 |
| Dec 31, 2019 | 1,000.00 |
| Jun 30, 2019 | -2,000.00 |
| Jun 30, 2019 | -2,000.00 |
| Mar 31, 2019 | 54,000.00 |
| Mar 31, 2019 | 54,000.00 |
| Dec 31, 2018 | 10,000.00 |
| Dec 31, 2018 | 10,000.00 |
| Mar 31, 2017 | 1,000.00 |
| Mar 31, 2017 | 1,000.00 |
| Dec 31, 2016 | 7,000.00 |
| Dec 31, 2016 | 7,000.00 |